News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Article May 30, 2024 Alimentiv DDW 2024 Presentations If you’ve missed some of our lecture presentations and poster sessions, reach out for more information…. Read Now
News May 13, 2024 Alimentiv: A Global GI-Focused CRO with end-to-end clinical trial services and imaging solutions leading with innovation at DDW 2024 London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease… Read Now
Article Mar 19, 2024 Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024 Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide,… Read Now
Article Jan 10, 2024 Bayesian innovations to supplement open-label trials Clinical trials in Crohn’s Disease face additional complexity as biologics provide additional treatment options but may require combination treatments to reach optimal efficacy. A Phase… Read Now
News Jan 8, 2024 Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective… Read Now
